These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8135917)

  • 1. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy.
    Eckman MH; Levine HJ; Pauker SG
    N Engl J Med; 1993 Sep; 329(10):696-702. PubMed ID: 8135917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal oral anticoagulant therapy in patients with mechanical heart valves.
    Cannegieter SC; Rosendaal FR; Wintzen AR; van der Meer FJ; Vandenbroucke JP; Briët E
    N Engl J Med; 1995 Jul; 333(1):11-7. PubMed ID: 7776988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy.
    Bussey HI; Force RW; Bianco TM; Leonard AD
    Arch Intern Med; 1992 Feb; 152(2):278-82. PubMed ID: 1739354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
    Aujesky D; Smith KJ; Roberts MS
    Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inter-institute variations in International Normalized Ratio and thrombotest].
    Nozawa T; Hayashi S; Naiki S; Niiya K; Asanoi H; Inoue H
    J Cardiol; 1998 Aug; 32(2):89-94. PubMed ID: 9752617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prothrombin time and its standardization].
    Kagawa K
    Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensity of oral anticoagulant therapy after heart valve replacement].
    Stenzinger W
    Z Kardiol; 1998; 87 Suppl 4():37-41. PubMed ID: 9857465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulation therapy after mechanical prosthetic heart valve replacement with special reference to international normalized ratio (INR)].
    Chikada M; Yagyu K; Kotsuka Y; Furuse A
    Kyobu Geka; 1994 Oct; 47(11):895-8. PubMed ID: 7967256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in antithrombotic therapy for patients with mechanical heart valves.
    Bussey HI; Lyons RM
    Pharmacotherapy; 1998; 18(3):451-5. PubMed ID: 9620096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of oral anticoagulation therapy by INR self-management.
    Horstkotte D; Piper C
    J Heart Valve Dis; 2004 May; 13(3):335-8. PubMed ID: 15222277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [International normalized ratio (INR) for optimal anticoagulant therapy].
    Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S
    Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major hemorrhagic and thromboembolic complications in patients with mechanical heart valves receiving oral anticoagulant therapy.
    Trzeciak P; Zembala M; Poloński L
    Heart Surg Forum; 2010 Apr; 13(2):E80-5. PubMed ID: 20444682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboembolic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation].
    Kanaoka Y; Tanemoto K; Murakami T; Kuroki K
    Kyobu Geka; 2000 Aug; 53(9):754-8. PubMed ID: 10935402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of different intensities of anticoagulation in patients with prosthetic heart valves.
    Saour JN; Sieck JO; Mamo LA; Gallus AS
    N Engl J Med; 1990 Feb; 322(7):428-32. PubMed ID: 2300106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.